Gene · 4131
NIH grants1,454
NIH grants whose papers are about the gene, through NIH's grant-paper links.
21 to 40 of 1,454
Download this page as JSON| Grant | Title | MAP1B papers | Newest fiscal year |
|---|---|---|---|
| P51OD011092 | Support for National Primate Research Center | 2 | 2025 |
| R01AG050658 | Pathogenic Roles for Microtubule Stabilization Pathways in Alzheimers disease | 2 | 2025 |
| R01EY021797 | Development of Stem Cell-based Therapies for Limbal Stem Cell Deficiency | 2 | 2025 |
| R24AA019431 | Monkey Alcohol Tissue Research Resource (MATRR) | 2 | 2025 |
| R24HD000836 | Laboratory of Developmental Biology | 2 | 2025 |
| R35GM149349 | Intracellular transport and organelle biology at the nanoscale: A multidimensional super-resolution approach | 2 | 2025 |
| U01NS120901 | A Phase-2b, Double-Blind, Randomized Controlled Trial to Evaluate the Activity and Safety of Inebilizumab in Anti-N-methyl-D-aspartate receptor (NMDAR) Encephalitis and Assess Markers of Disease | 2 | 2025 |
| U54MD012392 | RCMI Center for Health Disparities Research | 2 | 2025 |
| UL1TR002345 | Washington University Institute of Clinical and Translational Sciences | 2 | 2025 |
| ZIAAG000311 | ALZHEIMERS RESEARCH PROJECT: Design And Development Of Experimental Therapeutics ((Systemic & Neurodegenerative Disorders and Alzheimer's Disease) | 2 | 2025 |
| ZIADE000664 | Characterization of Molecular Pathways in Chronic Pain Conditions | 2 | 2025 |
| DP1DA054373 | Identifying specific genetic pathway interactions for drug use and abuse through integrative omics | 1 | 2025 |
| I01BX005015 | SDR: Genomic analysis of blast tube induced TBI in mice | 1 | 2025 |
| IK2RX003253 | Exercise and pharmacological LRRK2 inhibition for preventing PD | 1 | 2025 |
| K01AG071689 | Integrated multi-omics approach to identify early protein biomarkers in Alzheimer's disease and cognitive decline | 1 | 2025 |
| K12CA090354 | Training Program in Nervous System Tumors | 1 | 2025 |
| K12GM081259 | IRACDA at the University of Pennsylvania: Penn Postdoctoral Opportunities in Research and Teaching (PennPORT). | 1 | 2025 |
| K23AR077073 | Racial Differences in Biomarkers and Therapeutic Targets for Chronic Itch | 1 | 2025 |
| K24AR060297 | Scleroderma Twin Study and analysis of Estrogen in patients with dcSSc | 1 | 2025 |
| K99GM151484 | Identification and Characterization of Functional lncRNAs in human cells | 1 | 2025 |
Source NIH's project filesgene-search-2026-11-11-0.2.0
Sources 12
- ClinicalTrials.gov's posted results, through CTTI's AACTFreely available. Acknowledgement requested
- ChEMBL, through Open TargetsCC BY-SA 3.0
- ClinicalTrials.govNo license stated
- EMBL-EBI's patent proteinsNo added restrictions. Attribution expected
- GenBank's patent filesNo restrictions from NCBI. Submitters may hold rights
- HGNCCC0
- NCBI GenePublic domain (US government)
- NIH's project files and grant-paper linksPublic domain
- Open TargetsCC0 1.0
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0
Each source's terms
- ClinicalTrials.gov's posted results, through CTTI's AACTClinicalTrials.gov data via Aggregate Analysis of ClinicalTrials.gov (AACT), CTTI. CTTI makes its materials freely available and requests acknowledgement. https://aact.ctti-clinicaltrials.org/documentation/299
- ChEMBL, through Open TargetsCC BY-SA 3.0, for the parts from ChEMBL. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- ClinicalTrials.govnone stated
- EMBL-EBI's patent proteinsEMBL-EBI's patent protein files from the EPO, JPO, KIPO and USPTO. EMBL-EBI: "EMBL-EBI itself places no additional restrictions on the use or redistribution of the data available via its Data Resources and Tools other than those provided by the original data owners" and "EMBL-EBI expects attribution (e.g. in publications, services or products) for the use of any of its Data Resources and Tools." Read on 11 Nov 2026 at https://www.ebi.ac.uk/about/terms-of-use
- GenBank's patent filesGenBank's patent files. NCBI: "NCBI places no restrictions on the use or distribution of the GenBank data. However, some submitters may claim patent, copyright, or other intellectual property rights in all or a portion of the data they have submitted." Read on 11 Nov 2026 at https://www.ncbi.nlm.nih.gov/genbank/about/
- HGNCCC0: https://www.genenames.org/about/license/
- NCBI GeneNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- NIH's project files and grant-paper linksPublic domain (NIH RePORTER)
- Open TargetsCC0 1.0. Open Targets asks that users cite its latest paper: Buniello et al. 2025, Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery, Nucleic Acids Research 53(D1):D1467, PMID 39657122. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0. UniProt's licence file: "All databases and documents in the UniProt FTP directory may be copied and redistributed freely, without advance permission, provided that this copyright statement is reproduced with each copy." UniProt asks that users cite its latest paper: The UniProt Consortium, UniProt: the Universal Protein Knowledgebase in 2025, Nucleic Acids Research 53:D609-D617, https://doi.org/10.1093/nar/gkae1010. Read on 9 Nov 2026 at https://www.uniprot.org/help/license
ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.
For software
Read this list from software.
Twenty rows a page, as JSON. No key.
GET https://conductscience.org/api/genes/v1/4131/grants?page=2